If current results will be confirmed by further prospective studies 68Ga-PSMA PET/CT should be included, in addition to MRI of the pelvis, in the recommendations and society guidelines to evaluate disease extent in patients with prostate cancer. This evidence concerns the gene FOLH1 and Familial prostate cancer.